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Abstract
Skin grafts are used in a variety of medical procedures including burn treatment, skin
cancer removal, chronic wound/ulcer treatment, skin infections and diseases, large wound closure
and in elective plastic surgeries. Ideally, skin grafts are harvested directly from the patient.
However, in some cases, direct harvesting of skin grafts is not possible. In these situations, an
equivalent skin substitute obtained through another source is utilized. There will always be a
greater risk of rejection in such cases and therefore is only intended to be a temporary treatment.
A possible solution to lessen the risks and issues associated with skin grafts is to use a 3D printer
to print functional skin tissue made from the patient’s own cells.
Extensive research has already explored 3D printing of keratinocyte and fibroblast cells
which comprise the majority of cells in the skin. However, skin composed of only these two cell
types lacks some important functions such as pigmentation. Beyond its aesthetic value,
pigmentation is essential for protection from UV radiation, which can lead to DNA damage and
skin cancer. The purpose of this research is to explore bioprinting melanocytes as the first step
toward ultimately incorporating them with keratinocyte and fibroblast cells to produce skin, which
is capable of developing pigmentation when exposed to UV light.
An experiment using cultured melanocytes was performed. Four test groups were exposed
to multiple doses of UV radiation and subsequently analyzed to determine if melanin was
produced. Cells that were manually seeded onto collagen had the highest percentage of live cells
followed closely by bioprinted melanocytes yielding 182 ± 39% and 162 ± 10% respectively.
Melanocytes were shown to be successfully printed with significant cell growth and still expressed
melanin after UV exposure. Future research may focus on how melanocytes can best be printed
and incorporated with keratinocytes and fibroblasts to produce skin that acts as a physical barrier
for the body and can also develop pigmentation following UV exposure.
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Chapter 1: Introduction
1.1 Skin: Cutaneous Functions and Structure
Skin covers the entirety of the human body. Being the largest organ, skin has many
important functions that can be divided into three categories: protection from the external
environment, regulation of internal conditions and many sensory functions.
Above all, skin serves to protect the body from external environmental harm that can result
from mechanical forces, chemical interactions, extreme thermal fluctuations, harmful UV radiation
and pathogens [1]. Skin acts as a layer of protection and as a cushion to deeper bodily organs. For
example, if the skin is hit by an object, the outermost skin cells harden to protect from further
damage [2]. The skin also protects internal organs from chemical interactions. If an acid or base is
exposed to an internal organ, severe damage would occur quickly. Skin is significantly tougher
than internal organs and therefore acts as a barrier to chemicals. Although the skin may be injured
and damaged, if the chemical is cleaned off quickly, damage to internal organs is avoided [3]. In
cases where the body is exposed to extremely hot or cold objects, skin contains nerves that detect
these temperatures and sends impulses to the brain and reacts accordingly [4]. To protect the body
from harmful UV radiation, skin develops pigment through melanin to block the radiation that
would otherwise cause damage and mutations to the DNA resulting in skin cancer [5]. Lastly, skin
protects the body from invading pathogens. On unbroken skin, urea, salt and water in sweat help
to inhibit bacterial growth [6]. In the case of broken skin, bacteria and other pathogens may enter
but will encounter phagocytes that will try to destroy them before they can penetrate to deeper
tissues and organs [1].
Skin also serves to maintain certain internal conditions including thermoregulation and
water balance homeostasis [1]. If the body temperature begins to increase to unsafe levels, sweat
glands in the skin release sweat that evaporates to decrease its temperature. Also, blood vessels,
which are found abundantly in the skin, can vasodilate or expand the diameter of the vessel to cool
down the body. When the vessels dilate, more blood can flow allowing for heat dissipation. If the
1

body temperature begins to decrease to unsafe levels, blood vessels constrict, also known as
vasoconstriction, resulting in less heat loss through the skin. Skin also contains hair follicles which
produce hairs that act as an insulating layer. The outermost layer of skin also prevents liquid loss
helping to avoid dehydration. If the body does not have a sufficient amount of water in the blood,
it begins to become more concentrated and the overall blood volume begins to decrease [7]. This
causes the blood pressure to lower and the heart, in turn, increases its rate and strength of
contractions. After an extended period of time, dehydration can result in unconsciousness, seizures
or death if not remedied.
Skin is classified as a sensory organ, which allows the body to obtain immense information
about our environment. Skin can detect several different types of sensations including pain, touch,
texture, temperature, pressure and vibration [8]. With so many important roles, healthy, functional
skin is very important to the human body. Therefore, when severe injuries to the skin occur, it is
imperative that a skin replacement or substitute is used to cover the wound.

Illustration 1.1: Anatomy of human skin. Reprinted from [9] with written permission.
For the National Cancer Institute © 2008 Terese Winslow, U.S. Govt. has certain rights
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Skin is a complicated organ composed of many different types of cells that have distinctive
functions. To understand its structure, skin can be separated into three layers: the epidermis, the
dermis and the hypodermis with a basement membrane separating the epidermis and dermis. The
outermost layer of skin is called the epidermis. The epidermis is responsible for providing a
waterproof barrier to protect the body from the environment as well as pigmentation. This layer of
skin continuously sheds and regenerates every one to two months [1]. The epidermis is composed
of four types of cells: keratinocytes, melanocytes, Langerhans cells and Merkel cells.
Keratinocytes make up the majority of the epidermis and form the outermost layers of the skin.
Keratinocytes produce keratin, a tough fibrous protein, and can take different shapes such as
squamous (flattened), columnar and cuboidal depending on their location in the epidermis. Due to
the tightly-packed arrangement of the top layer of stratified squamous keratinocytes, it provides
low permeability of the skin to water, enabling skin to be waterproof [1]. They are also important
in wound healing as they are the first type of cell to migrate to the location of an injury [10].
Melanocytes are found in the basal layer of the epidermis. They are responsible for producing
pigmentation that protects the body from UV radiation damage. Langerhans cells are part of the
immune system that act as antigen-presenting cells [11]. These cells perform phagocytosis, similar
to macrophages, to encapsulate pathogens and then communicate with other immune cells to help
destroy the pathogen. Lastly, Merkel cells are receptors that sense touch.
Separating and connecting the epidermis and the dermis is the basement membrane. The
basement membrane is an extracellular matrix that consists of different types of collagen, laminins
and fibrillin microfibrils. Apart from keeping the keratinocytes and the melanocytes in the
epidermis, it also allows for macrophages, lymphocytes and nerve cells to cross between the
epidermis and dermis. Additionally, it also allows for oxygen and nutrients to penetrate into the
epidermis. This is very important because the epidermis lacks blood vessels. The basement
membrane is also important because it helps to promote the proliferation, differentiation and
survival of the cells in the skin [12].
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The next and thickest layer of skin is the dermis. The dermis consists of four main
components: fibroblasts, elastin, collagen and an extracellular matrix. Fibroblasts make up the
majority of cells in the dermis. Fibroblasts produce elastin, collagen, the extracellular matrix and
structural fibers [13]. Elastin is an elastic protein fiber that allows the skin to be flexible. Strength
is provided to the dermis in the form of collagen fibers. The extracellular matrix is gel-like and
helps to protect the body from compressive forces by acting as a shock absorber [1]. Other features
of the dermis include sweat glands, hair follicles, sebaceous glands, nerves and many types of
immune system cells [13]. Sweat glands produce sweat, which is important in temperature
regulation. Hair follicles also help in temperature regulation by producing hair. Sebaceous glands
produce sebum that helps to lubricate the hair and skin. The dermis also contains several types of
nerves that allow the body to perceive pain, touch, both subtle and extreme changes in temperature
and the sensation of an itch. The bottom layer of the skin is the hypodermis. This layer is composed
of connective tissue and adipose fatty tissue. The connective tissue connects the skin to the
underlying tissues. The fatty tissue helps to insulate the body as well as protect internal organs and
store energy in the form of fatty acids [1].
As it has been shown above, skin is an important and complex organ with many different
functions that are necessary for life. Next, the medical need for skin replacements and substitutes
will be discussed as well as the available options and issues associated with them.
1.2 Applications for Skin Substitutes
As discussed in the previous section, skin is an important organ that performs many
different functions. There are several factors that make functional skin necessary for life. Damaged
skin loses its ability to retain vital liquids leading to dehydration, hypovolemic shock and organ
failure [14, 15]. Open wounds are also more at risk of contracting an infection, which can lead to
sepsis [16]. Damaged skin losses its ability to regulate temperature which can lead to heat loss and
hypothermia [17]. Heavily scarred skin can also restrict the movement of joints [18]. Normally,
skin has the ability to regenerate itself, however sometimes this is not the case and replacement
4

skin is required [1]. Such injuries, as well as the available types of skin replacements will be
described in the following sections.
1.2.1 Injuries and Diseases That Require Skin Replacement Therapy
As mentioned previously, healthy skin has the ability to regenerate itself. However, in the
case of large wounds or chronic wounds, skin may not be able to heal itself. Small wounds are
normally closed using stitches, medical glue, staples or bandages. Large wounds typically require
skin replacement. Several of the prevalent injuries that require skin replacement will be discussed
subsequently.
The most common injury that requires skin replacement is burns. In 2016, approximately
486,000 people received medical treatment for burn injuries in the United States [19]. In 2004,
almost 11 million people received medical treatment for burns worldwide [20]. The treatment
required for a burn depends on the classification of the burn. The following table describes the
different classifications of burns and the type of treatment they require [21, 22]. Third- and fourthdegree burns require skin replacement procedures as part of patient therapy.
Table 1.1: Classifications of Burns

Classification

Skin Layers

Symptoms

Damaged
-Red

First-Degree

-Epidermis

-Home care

-Painful
-No blisters
-Peeling as healing begins

Second-Degree

Treatment Type

-Heals within 7-10 days
-Little to no scarring

-Red

-Home care

-Epidermis

-Painful

-Heals within 2-3 weeks

-Dermis

-Blisters

-Little to no scarring

-Thickening of skin

-Changes in pigmentation

5

Classification

Third-Degree

Skin Layers
Damaged

Symptoms

Treatment Type

-Epidermis

-White and charred

-Professional medical treatment

-Dermis

-Very painful

-Severe scarring and risk of

-Subcutaneous tissue

-Raised and leathery texture

infection without treatment

-Dermis

-Black and charred

-Professional medical treatment

-Subcutaneous tissue

-Not painful (nerve endings

-Severe scarring, risk of infection,

-Muscles

are destroyed)

and organ damage without

-Tendons

-Raised and leathery texture

treatment

-Epidermis

Fourth-Degree

-Bones

Another injury type that requires skin replacement is chronic wounds and ulcers that do
not heal on their own. This is a common affliction for those suffering from diabetes. Non-healing
diabetic foot ulcers can easily become infected and are the most common foot injuries that lead to
lower extremity amputations [23]. In 2012, approximately 29.1 million people in the United States
were diabetic [24]. Of those, 10-15% will develop a chronic foot ulcer during their lifetime,
resulting in about 3 million people requiring medical treatment [25]. Treatment includes
debridement of the wound, which removes the dead tissue and increases blood flow to the area
[26]. The ulcer can either heal on its own with proper wound care but in some cases skin
replacement therapy is required [26].
Other procedures that may require skin replacements include the removal of skin cancer
tumors, certain elective plastic surgeries and closure of large wounds and other traumas. Skin
cancer is the most common cancer in the United States [27]. Nearly 9,500 Americans are diagnosed
with skin cancer every day [28]. To treat skin cancer, a surgeon will excise the tumor and some of
the healthy skin surrounding the tumor. The wound is then carefully stitched back together and
will most likely leave a scar. In cases involving large tumors, the wound that remains may be too
large to close with stitches or other conventionally surgical means. Replacement skin therapy is
required in such cases. Breast augmentation and other cosmetic forms of elective plastic surgery
may require the use of extra skin. In 2015 in the United States, a reported 305,856 patients
6

underwent breast augmentation [29]. To create the space where the implant will be placed, a tissue
expander is inserted and filled with liquid slowly over months to stretch the skin gradually. The
other option is to use replacement skin to surround the implant [30].
Another use for skin replacement is during the treatment of certain types of skin infections
and blood disorders. Necrotizing fasciitis, also known as the flesh-eating infection, is an infection
caused by bacteria that infects the fascia and can damage or kill the surrounding tissues including
skin and fat [31]. Once in the body, this disease can quickly spread and will cause death if not
treated promptly. Treatment involves strong antibiotics and removal of dead tissue. These wounds
can either be closed using conventional surgical techniques or using skin replacement therapy [32].
Purpura fulminans is a blood disorder, more common in infants, that can quickly lead to skin
necrosis [33]. This disorder involves a deficiency in protein C activity that causes the blood to clot
in small blood vessels restricting oxygen flow to the skin and other organs [34]. Treatment includes
several types of medication and supportive treatments to combat the clotting abnormalities,
debridement of the dead skin and skin replacement therapy [34].
Replacement skin can also be very useful in research on skin diseases and drug testing.
Many different animals are used as skin research models including mice, rats, rabbits, primates
and guinea pigs. However, the pig is most commonly used because pig skin is very similar to
human skin both anatomically and structurally [35]. There are major differences that exist between
pig skin and human skin. Pigs lack eccrine glands, have different hair follicle shapes and possess
an extra interfollicular muscle [36, 37]. Therefore, when pig skin is used as a model for human
skin, there is a chance of variation of results. The best option for skin research models would be
human skin of which replacement skin may be used.
1.2.2 Skin Grafts and Other Skin Substitutes
In cases of dramatic skin loss, equivalent skin replacement is required as part of patient
therapy. There are two types of skin replacements currently available: skin grafts and synthetic
skin substitutes and dressings. The more common therapy is skin grafting. Skin grafting is the
7

process in which a portion of healthy skin is harvested and transplanted at the site where skin has
been compromised in some manner. There are three categories of skin grafts: autografts, allografts
and xenografts. Autografts are skin grafts where skin is obtained from the patients themselves.
Allografts obtain skin from other humans most commonly cadavers. Xenografts obtain skin from
animals most commonly pigs. Allografts and xenografts are only a temporary form of treatment
as the body will ultimately reject the foreign skin in three to ten days [38, 39]. These types of skin
grafts are used when patients are too badly injured or are too sick to perform an autograft or if the
injury only requires temporary protection to allow the skin to heal on its own [40]. However, for
long-term treatment of skin injuries autografts are the best option due to the much lessened risk of
rejection.
There are four types of autografts that are used to treat different skin injuries: splitthickness grafts, full-thickness grafts, composite grafts and cultured skin grafts. Split-thickness
grafts are composed of only a few layers of skin more specifically the epidermis and part of the
dermis. Due to the fact that the grafts lack blood vessels and other glands, they tend to be slightly
discolored compared to the surrounding skin [40]. The donor site will heal but requires medical
treatment and dressings. Similarly, full-thickness grafts are composed of the epidermis and the
entire dermis, leaving the donor site in need of suturing or another form of skin replacement
therapy. This form of grafting tends to be more cosmetically similar to the surrounding skin and
functions more normally [40]. Composite grafts consist of full-thickness grafts as well as muscles,
tendons, cartilage or bones. Again, the donor site will require medical attention and treatment. The
final type of autograft is a cultured skin graft produced in a laboratory. This graft is made by
collecting keratinocytes and growing them into very thin sheets meaning that only the epidermis
can be replaced with this grafting method. One advantage to this method is that it requires the
smallest amount of donor tissue. However, currently this method tends to have higher rates of graft
loss and infection [39].
The type of autograft is chosen depending on the depth of skin loss and location of injured
skin on the body. Superficial injuries that do not extend deep into the skin are treated with split8

thickness grafts. Full-thickness autografts would be used to treat a burn on the face, joints or any
other location where cosmetic appearance or function is important. Autografts are also commonly
meshed which allows the graft to cover more wound area as it heals [41]. This means that surgeons
only need to remove about 1/6th of the area of healthy skin for the graft as compared to the damaged
area [39]. Meshed skin grafts also allow for fluid drainage reducing the incidence of infection [40].
Skin is harvested for autographs from the patient’s thighs, buttocks, abdominal wall or scalp,
places where scarring will not be noticed.
In cases where donor skin is not able to be harvested (i.e. extensive burns) synthetic skin
is a viable option. There are two types of synthetic skin grafts available including acellular and
cellular allogenic skin substitutes. Acellular skin substitutes are usually made of a nylon mesh
dermis and a silicon membrane epidermis. They are sometimes embedded with collagen and other
chemicals to help the graft adhere to the wound and accelerate healing [42]. These grafts are only
a temporary solution until autografts are available. Cellular allogenic skin substitutes are similar
to acellular skin substitutes in that they are composed of a nylon mesh dermis and silicone
epidermis. The main difference is that cellular allogenic skin substitutes contain viable neonatal
fibroblasts that help to produce a collagen cellular matrix and other growth factors to advance
wound healing [42]. Both acellular and cellular allogenic skin substitutes are only a temporary
treatment and will need to be replaced eventually [42].
1.2.3 Issues Associated with Skin Grafts
There are many issues and complications associated with skin grafts. The likelihood of
complications is actually doubled given that they can arise at both the site of the transplanted graft
and the donor site. Complications often lead to skin graft rejection and failures which require
further surgeries to repair. Skin grafts can experience failures if one or more of the following occur:
the graft fails to adhere to the wound, the body rejects the graft or the graft itself dies.
Complications can be either immediate or long-term and can be further divided into three
categories: severe complications, functional issues and cosmetic variations.
9

Table 1.2: Skin Graft Complications

Immediate Complications
Severe Complications

Long-Term Complications
Functional Issues

Cosmetic Variations

Hematomas

Contraction

Depression of wound

Seromas

Loss or reduced skin sensation

Altered texture

Excessive Bleeding

Dry and itchy skin

Scarring

No sweat gland/hair follicles

Discoloration

Poor excision of dead tissue
from the wound
Shearing/displacement of graft

Chronic pain

Inadequate blood supply
Infection
Complications are classified as severe if they pose the threat of graft failure. Hematomas
(clotted blood underneath the graft), seromas (clear fluid that develops underneath the graft) and
excessive bleeding can occur following transplantation and can act as a barrier that causes the graft
to have trouble adhering [43]. During surgery, if the wound is not properly debrided, dead tissue
remains underneath the graft, which can affect the healing process [44]. The skin graft can be very
fragile for weeks after transplantation. As a result, the graft must be protected from excessive
movement to ensure the graft is not displacement or completely detached [45]. Another dire
complication that quickly leads to failure arises from inadequate vascular supply to the graft [43].
This can be the result of either swelling of the surrounding skin restricting blood flow or that the
blood vessels were damaged and cannot supply adequate blood flow. There is also a possibility
that the surrounding blood vessels do not grow into the graft resulting in inadequate
vascularization. In all of these scenarios, the graft tissue will die and another grafting procedure
will be necessary. The possibility of infection is a severe complication that always exists following
any form of surgery. Infection can occur at either the graft or at the donor site and can eventually
lead to graft death or sepsis [46, 47].
Long-term complications usually tend to be functional or cosmetic in nature. Some
complications can affect skin’s function. Skin grafts have the tendency to contract or shrink during
10

the healing process [48]. This complication is only cosmetic unless it occurs over a joint.
Contraction of skin over a joint can result in reduced mobility. During the harvesting of the graft,
nerve endings, sebaceous glands, sweat glands and hair follicles can be damaged [43, 48]. This
results in loss of sensation, dry, itchy skin or the inability to regulate temperature at the graft site.
Many patients also report chronic pain at both the graft site and donor site [45]. There are also
several subtle and obvious cosmetic variations that occur between skin grafts and the surrounding
skin. Once healed, the skin graft is slightly depressed and indented from the surrounding skin [44].
This results in an uneven skin texture, which is unwanted in visible areas such as the face. Scarring
also occurs around the perimeter of the graft and can have an impact on skin’s form and function
[3, 47, 48]. Scar revision surgeries are often employed to minimize the appearance of scars and
restore skin function if possible [49]. The differences in pigmentation, often seen, between the
graft and the surrounding skin are obvious cosmetic complications [44, 50]. Melanocytes are often
damaged during the grafting procedure and may result in a graft that can be lighter or darker than
the surrounding skin [50]. This can create further complications in the form of skin cancer through
UV radiation exposure.
Although not all of the previously mentioned complications would be solved by bioprinting
of skin from the patient’s own cells, two issues would be immediately prevented. Firstly, cell
rejection would not occur because the graft would be comprised of the patient’s own skin cells.
Secondly, using bioprinting to produce skin grafts would eliminate the need to surgically remove
skin from the patient. Since graft complications can also occur at the donor site, the percentage of
complications would essentially decrease by half. Assuming that one day fully-functional skin
tissue can be bioprinted, many of the functional and cosmetic issues can be lessened long-term.
The functional complications of reduced skin sensation, dry and itchy skin and inability to regulate
temperature would be eliminated if nerve cells, sebaceous glands, sweat glands and hair follicles
can be successfully integrated and printed. Discoloration can be corrected once functional
melanocytes can be printed. This would also help to protect the skin from UV photodamage. It has
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also been shown that cells printed directly into the wound of burn patients resulted in printed skin
that blended into the surrounding skin with less scarring [51].
1.3 Melanocytes, Melanin and Inducing Pigmentation
In the following section, melanocytes, the main cells of interest in this thesis, will be
discussed as well as their role in melanin production and pigmentation.
1.3.1 Melanocytes
Melanocytes are a type of specialized skin cell that is responsible for pigmentation.
Melanocytes only account for 3-7% of epidermal cells in human skin [52]. However, melanocytes
have a very important function, the production of pigmentation. This pigmentation, also known as
melanin, acts to protect the body from the damaging effects of repeated UV radiation exposure.
Melanin and its production will be described in the following sections.

Figure 1.1: Melanocytes cultured at 48 hours. The center of
the melanocyte is ovate, but has two dendritic arms
extending outward.

Melanocytes are mainly found in the basal layer of the skin’s epidermis but are also found
in hair follicles, the iris of the eye, the inner ear, the nervous system, and even the heart [53]. As
shown in the figure above, melanocytes have an oval, dendritic shape that is important to
transferring pigment to the surrounding cells. The size and number of melanocytes are independent
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of race. Melanocytes are relatively the same size, on average around 7 µm in length [54]. However,
the size of melanocytes does vary slightly depending on their location on the body. There are about
1,200 melanocytes per mm2 of skin [55]. The melanocyte density in all skin types is virtually
identical, meaning that cutaneous pigmentation is the result of another phenomenon, which will
be discussed later [56, 57].
1.3.2 Melanin
Melanocytes produce melanin in special membrane-bound organelles called melanosomes
that are located in the cytoplasm [58]. There are two major types of melanin produced in the
melanosomes: pheomelanin and eumelanin. Pheomelanin is a reddish-yellow pigment whereas
eumelanin is a brownish-black pigment. Every melanocyte can produce both types of melanin.
Which type of melanin that is produced is determined by availability of substrates in the
melanosomes. For example, if thiols like cysteine, thioredoxin or glutathione are present,
pheomelanin will form. In the absence of thiols, eumelanin will form [54]. Interestingly, the type
of melanin produced can be predicted by the shape of the melanosome: eumelanin is synthesized
in more elliptical melanosomes compared to pheomelanin which is synthesized in more spherical
melanosomes [59].
Visible pigmentation correlates to the amount of melanin produced by melanocytes. Skin
color is determined by the ratio of eumelanin to total melanin content [60]. Individuals with more
eumelanin will be more dark-skinned than others with less eumelanin. Interestingly, light and dark
skinned individuals contain similar amounts of pheomelanin. Other than their color, pheomelanin
and eumelanin have another difference. Eumelanin has better protective properties against UV
radiation than pheomelanin [61]. Therefore, darker individuals have better protection against the
harmful effects of UV radiation exposure meaning that these melanocytes incur much less DNA
damage [57]. Light skinned individuals are 30-40 times more likely to develop skin cancer as
compared to darker individuals [62]. Other studies have determined that pheomelanin has more
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phototoxic potential and sometimes becomes mutagenic after long wavelength UV exposure [63,
64].
Melanin is beneficial to health in several ways. Repeated UV radiation exposure is widely
considered the main cause of the formation of multiple types of skin cancers. First and foremost,
melanin plays a photoprotective role to help protect skin against UV-induced photodamage [65].
Melanin, more specifically eumelanin, acts as a physical barrier that scatters UV radiation and also
as a broadband UV absorbent filter that reduces the penetration of UV through the epidermis [66].
Beyond UV light absorption and scattering, melanin plays a role in free radical scavenging,
coupled oxidation-reduction reactions and ion storage to help combat the negative effects of
repeated UV exposure [67, 68, 69]. However, melanin has been compared to a two-edged sword,
also having some harmful, toxic effects on melanocytes with respect to the long-term
consequences of UV radiation [65, 70].
1.3.3 Inducing Pigmentation in Melanocytes
The main function of melanocytes is to produce pigmentation, in the form of melanin, to
help protect against the damaging effects of UV radiation. To induce the melanin formation in
melanocytes, they must first be exposed to UV radiation. Tanning can be described as the increase
in production and dispersion of melanin and is the result of repeated sun exposure [71]. Therefore,
UV radiation is capable of the direct stimulation of melanogenesis, the process of producing
melanin.
UV radiation can be divided into three parts based on wavelength: UV-A (320-400 nm),
UV-B (280-320 nm), and UV-C (200-280 nm). No UV-C radiation reaches the Earth’s surface due
to the fact that it is filtered by the ozone layer. Lower wavelengths correspond to higher UV
absorption by melanin [63, 72, 73]. Increasing doses of UV-B radiation causes a decrease in
melanocyte cell survival [74]. Other studies have shown that when melanocytes are exposed to
higher wavelengths, the results are molecular lesions in their DNA, which contribute to cell death
[75]. A wavelength of 365 nm was found to cause the most concentrated number of lesions.
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However, it has also been shown that UV-B radiation is 3-4 times more effective than the same
physical dose of UV-A radiation at inducing tanning, photodamage, erythema and skin cancer [76,
77, 78]. This implicates UV-B radiation as the primary mutagen and as being more cytotoxic than
UV-A radiation. Nevertheless, UV-A radiation can still cause DNA damage indirectly through the
generation of reactive oxygen species and can penetrate deeper into the dermis than UV-B
radiation [79].
After UV exposure, melanocytes begin to produce melanin inside of melanosomes.
Tanning of the skin occurs as the result of melanocytes dispersing melanosomes to the surrounding
cells using their dendrites. Tanning occurs in three phases: IPD, PPD and DT. The first phase is
immediate pigment darkening, IPD, which starts within minutes and occurs for several hours [72].
Persistent pigment darkening, PPD, starts within hours and continues for several days [73].
Delayed tanning, DT, occurs after several days [80]. Both IPD and PPD have a stronger response
to UV-A than to UV-B. Melanosomes dispersed quickly when exposed to UV-A radiation but did
not occur when exposed to UV-B radiation [81]. Therefore, UV-A radiation is more efficient at
tanning whereas UV-B radiation is more efficient at inducing erythema [65]. However, it has been
shown that UV-A exposure generates significantly more reactive oxygen species, which have
negative effects on cells [82].
In an experiment conducted in 2006, human skin was exposed to multiple doses of UV
radiation of which the wavelength was not specified [57]. Biopsies were obtained from an
unirradiated area of the skin as a control, and radiated areas of the skin at one day, one week, three
weeks and five weeks after the exposures began. Melanin content was measured for each of the
samples and averaged. Melanin content began to increase by the first week, but of no significance.
At three weeks, melanin content slightly increased. It continued to increase and was two times
greater at five weeks than unirradiated samples.
In an experiment conducted in 1987, the effect of UV radiation on melanin production in
cultured melanocytes was studied [71]. A 285nm UV lamp was used to expose cultured
melanocytes to a dosage of 2.4 mJ.cm-2 daily for ten days. After one dose, melanin content
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increased by 20%. After four doses, the amount of melanin doubled. After seven doses, melanin
content continued to rise to 400%. However, by the tenth dose, proliferation was inhibited and cell
numbers either remained constant or slightly decreased. This study also found that UV radiation
changes the morphology of melanocytes. Melanocytes that were exposed to UV radiation showed
an increased number and length of dendrites as compared to unirradiated melanocytes. There were
also a greater number of melanosomes and a higher average degree of melanization in the samples
that were exposed to repeated UV radiation.
The ability of melanocytes to produce visible pigmentation is dependent on the amount and
size of melanosomes, the type of melanin produced and the distribution of melanin to the
neighboring keratinocytes [10, 56, 57, 83]. Shown in the illustration below, an epidermal melanin
unit is composed of one melanocyte and around 30-40 associated keratinocytes [84]. The dendritic
shape of the melanocytes help to transfer melanin granules, in the form of melanosomes, to the
associated keratinocytes. The melanosomes accumulate above the nucleus of the keratinocytes and
are shed with the top layer of epidermal cells [85]. Lighter-skinned individuals have less overall
melanin, which is found as clusters of melanosomes in the keratinocytes [57]. Darker-skinned
individuals have more melanin and the melanosomes are individually distributed in the
keratinocyte [57]. This process determines the skin color of the individual as well as the ability of
the skin to protect against UV radiation exposure [54]. Although the exact mechanism is still
unknown, both melanocytes and keratinocytes seem to play a role in actively regulating
melanosome transfer [86, 87]. It is also known that keratinocytes secrete paracrine growth factors
that influence melanocyte proliferation, melanogenesis, melanosome transfer, dendricity and
general survival of the cells [88, 89].
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Illustration 1.2: Epidermal Melanocyte Unit. Melanocytes and
keratinocyte interaction to produce and transfer melanin.
Reprinted from [90] with written permission.

There are four maturation stages of melanosomes [54, 67]. Stage I melanosomes are usually
spherical vacuoles that lack tyrosinase activity and internal structural components. Stage II
melanosomes are elongated, fibrillar organelles that are formed when a specific structural protein,
Pmel17, is present. There is still no melanin formation at this point. At stage III, melanosomes are
elliptical and melanin begins forming on the internal protein fibrils. At the final stage, stage IV,
melanosomes are filled with melanin and are classified as highly pigmented. Stage IV
melanosomes begin to lose tyrosinase activity and transferring of melanin to surrounding
keratinocytes begins.
1.4 Cell Bioprinting
Since its initial introduction in 1986, cell bioprinting has evolved into a very promising
way to generate viable replacement organs and tissues. The general concept of cell bioprinting is
to deposit cells in specific locations using a layer-by-layer printing approach. Similar as to how
printers print with ink, cell bioprinters print bio-ink that is composed of cells and other materials.
There are several different types of bioprinters in existence. Cell bioprinters can be separated into
two main categories: laser-assisted bioprinting and laser-free bioprinting.
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Laser-assisted bioprinters use a focused laser, beaming in pulses, through a lens and then
through the bio-ink ribbon to cause the formation of a droplet of bio-ink that is printed onto a
substrate in a specific location. The size of the droplet is dependent on the energy and duration of
the pulse. This printing method has high cell viability and can print high cell densities [91].
However, laser-assisted bioprinters commonly have very low printing speeds which makes
printing large amounts of materials non-feasible [91].
Laser-free bioprinters, commonly referred to as inkjet bioprinters, use a printer head that
contains a reservoir tank to hold the bio-ink, a nozzle through which the bio-ink is extruded and
an actuator to generate pressure that extrudes the bio-ink through the nozzle. Depending on the
type of actuator, the bio-ink flow may be continuous or in droplets. There are several different
types of actuators that are used in cell bioprinting: thermal, piezoelectric and solenoid valve. Each
of these actuators have the same function, to cause discontinuity in the stream of bio-ink. Actuatorbased bioprinters print significantly faster than laser-assisted bioprinters and have equivalent
percentages of cell viability [91]. However, due to the fact that micrometer-sized orifice nozzle
can become clogged with the cells, the cell density of the bio-ink must be significantly less than
the other types of bioprinters [91]. There is another type of laser-free bioprinter that uses a robotic
dispenser that dispenses a continuous stream of bio-ink directly onto a substrate. This type of
bioprinting, referred to as extrusion bioprinting, has the lowest associated cell viability but the
fastest printing speeds and can print the highest cell densities [91].
1.4.1 Inkjet Bioprinting
Inkjet printers have been commercially available for many years. The majority of the
technology resides inside the cartridge. Droplets are formed after small superheated vapor
explosions create a bubble which expands and propels small droplets of ink from each of the 400
nozzles [92]. Droplet size can be changed by adjusting the velocity of the ink, the pulse frequency
and the temperature gradient [93]. Each nozzle can print about 36,000 droplets per second [92].
Due to the fact that inkjet printers have high digital precision and control and have not shown any
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lasting, harmful effects on mammalian cells, inkjet printers are an ideal choice for use in tissue
engineering and most commonly used [93, 94].
Similar inkjet bioprinters have been created and tested by Clemson University to print
several different cellular materials [95, 96]. In 2003, researchers successfully printed viable E. coli
into complex patterns using a modified HP 550C printer controlled by simple software [95]. In
2004, the same group wanted to see if the same printer was capable of printing more sensitive
mammalian cells [96]. Hamster ovary epithelial cells and rat motoneurons were chosen to print
onto soy agar and collagen hydrogels. In the cartridge of the inkjet printer, temperatures can reach
upwards of 300ºC and high forces act on the cells as they are ejected through the nozzles [97]. Due
to the fact that mammalian cells are more sensitive to heat and mechanical stresses, viability of the
cells were tested after printing to see how many cells were lysed during the process. It was
observed that a very small number of cells were lysed during the printing process, averaging
around 3.3 ± 3.7%. However, a significant number of cells were lysed during the bio-ink
formulation, averaging around 15 ± 0.7%. This study proved that these cells could be delivered
using a thermal inkjet bioprinter. It was also shown that the bio-ink only increased in temperature
4º - 10ºC, not enough to damage the cells. Overall, more than 90% of the cells remained viable
during the entire printing process.
1.4.2 Current Research on Bioprinted Skin Tissue
There has been extensive research on the effect of bioprinting on different types of cells.
There has also been research on printing skin tissue that still lacks some of its major functions. In
a study conducted in 2010, mouse fibroblasts, human keratinocytes and human mesenchymal stem
cells were successfully printed together using a laser-assisted bioprinter [98]. The hydrogel used
to embed the cells for printing was made of collagen type I from rat tails. A cell survival rate of
about 98% was calculated for the printed cells. This study also demonstrated that printing did not
induce DNA strand breaks, leaving the genotypes unaffected and that printing the stem cells did
not affect the immunophenotyped or differential potentials. It was also observed that after the bio19

ink was printed, the cells contracted causing the collagen to shrink. However, this allowed for an
ample supply of oxygen and nutrients to be delivered to the cells by diffusion. The addition of the
stem cells did not integrate into the skin tissue; however, they did promote skin regeneration by
the secreted trophic factors. With all the findings of this study, it was concluded that the bioprinted
cells were viable and fully functional both in vivo and in vitro.
In another study conducted in 2011, an inkjet bioprinter was mounted onto a portable XYZ
plotting system that allowed the printer to print the cells and the hydrogel directly onto the wound
[51]. Human fibroblasts and keratinocytes were printed together simultaneously using separate
cartridges directly onto a wound on a mouse and then a pig. The bio-ink used to print was made
of the cells embedded in a hydrogel mixture of fibrinogen and collagen type I. After each layer
was printed, a layer of thrombin was printed to cross-link the fibrinogen. After the wound had fully
healed, human cells were found at the location of the wound and the general composition of the
printed skin appeared to be similar to the surrounding skin [51].
Thus far, fibroblasts and keratinocytes have been successfully bioprinted into multilayered
3D structures. The bioprinted skin equivalents have been shown to grow into the surrounding skin
whether it is grown ex vivo and then implanted or printed into wounds in situ. The reason that
these cells have been studied in depth is that fibroblasts and keratinocytes make up approximately
90-95% of all the cells found in the epidermis layer of skin [99]. In addition, by combining the two
cell types, the wounds can be covered effectively, liquid and protein loss can be prevented and
infections can be minimized. However, skin provides many other important functions including
UV radiation protection, regulation of body temperature, immunological functions, toxic
substance excretion, nerve sensations and vitamin D synthesis. For these functions to be included
in the bioprinted skin, the effects of bioprinting of other cells must be studied and subsequently
integrated into printed skin equivalents in a way to promote each cell’s function. Another problem
that must be studied is the lack of blood vessels. Without blood vessels, the skin will not be able
to receive ample oxygen supply and will die.
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1.4.3 Benefits and Advantages of Using Bioprinting
There are several reasons that have recently emerged that make the use of 3D printers very
beneficial to cell bioprinting. Firstly, this technology allows for customization and personalization
of products, in this case, organs [100]. The structure of skin can vary depending on its location on
the body. Being able to quickly alter the design can allow for different types of skin (i.e. delicate
facial skin versus thick abdominal flesh) to be manufactured. Secondly, 3D printing technologies
offer enhanced productivity in the form of increased resolution, accuracy and repeatability, which
are continuously improving [100]. Currently available bioprinters have the ability to precisely
control cell placement, delivery speed, cell concentration and drop volume [93, 94]. Lastly, 3D
printing can help to increase cost effectiveness for those seeking low production volumes or
designs that require frequent alterations [101].
To make fully functional skin, other cells must be integrated into the bioprinting process.
However, just adding these cells to the bio-ink would not guarantee their future functionality. The
cells must be printed in a way that the microenvironments mimic the original tissue structures [1].
Cells must be subtly combined with other cells, growth factors and scaffolds to enhance their
individual and overall functions [96]. Therefore, the ability of bioprinters to deposit the cells in
specific locations makes it possible to create these microenvironments.
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Chapter 2: Materials and Methods
In the following chapter, the specific materials, procedures and methods used for this
research will be discussed.
2.1 Materials
In this section, the materials used for this research will be discussed in detail. The materials
include the cells, growth media, collagen gel, inkjet bioprinter, ink cartridges, UV lamp, and the
live/dead assay.
2.1.1 Melanocytes and Growth Media
The cells used in the bio-ink were human, neonatal, primary epidermal melanocytes
(ATCC® PCS-200-012). These melanocytes were harvested from the foreskins of lightlypigmented individuals. The original vial of melanocytes was preserved at the second passage
which ensures high viability as well as high plating efficiency. The manufacturer guarantees at
least 15 population doublings after the first generation of cells [102].
The recommended growth media used to ensure survival and propagation of the cells was
a combination of Dermal Cell Basal Medium (ATCC PCS-200-030) supplemented with a
Melanocyte Growth Kit (ATCC PCS-200-041). The melanocyte growth kit includes rh insulin,
ascorbic acid, L-glutamine, epinephrine, calcium chloride and a proprietary formulation referred
to as M8 supplement. It is important to note that this supplement is free of cholera toxin as well as
phorbol 12-myristate 13-acetate (PMA). Although these substances help to promote melanocyte
growth, they are also used to suppress the growth of keratinocytes and fibroblasts [102]. If these
two substances are used, future research would experience inhibited growth of the printed
keratinocytes and fibroblasts, which make up the majority of skin cells in the epidermis. Utilizing
these substances would make incorporating the printed melanocyte cells with other printed
keratinocytes and fibroblasts to create pigment-capable 3D-printed skin tissue impossible. There
were also several additional supplements that could be added to the media including a gentamicinamphotericin B solution, a penicillin-streptomycin-amphotericin B antibiotic solution and phenol
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red. These additional supplements help to prevent bacterial infections and visually indicate if the
media and cell culture are near physiological pH. For this research, the only antibiotic solution
available initially contained only penicillin and streptomycin (HyClone™ Penicillin Streptomycin
100X Solution). Also, phenol red was not originally added to the growth media due to the fact that
it was unavailable. As a result, even though the growth media was meticulously tested with pH
strips throughout the course of the experiment, it was hard to maintain a pH of 7.2 [103].
Thereafter, phenol red (ATCC PCS-999-001) was obtained and added to the last bottle of growth
media that was used for the experiments. Phenol red is a pH indicator that turns different colors
depending on the pH of the solution. The growth media with a pH of 7.2 appears as an orange-red
color. The growth media was also passed through a vacuum filter to ensure that it was not
contaminated. The manufacturer indicates that this media is low-serum, meaning that it contains
less than 1.0% FBS fetal bovine serum [102]. The amount of FBS is an important factor during
3D printing of the melanocytes.
2.1.2 Collagen Gel
The melanocytes were printed onto a 12-well plate (CLS3513 Sigma®) lined with a layer
of collagen gel (Corning® Collagen I, Rat Tail, 100mg Product #354236). A thin layer of collagen
gel helps to promote cell attachment whereas a thicker layer helps to promote cell function [104].
Hydrogels also help prevent the printed cells from drying out which can negatively affect their
viability [96, 105]. Also, the collagen hydrogel acts as a cushion and mechanical support for the
melanocytes when they are printed due to the fact that they are ejected out of the printer nozzle at
a high velocity. The preparation of the collagen gel will be discussed in greater detail in the next
section.
2.1.3 Inkjet Bioprinter and Cartridges
The bioprinter used was a modified HP inkjet printer created by previous graduate students
in the department. Utilizing parts of an HP Officejet 330 inkjet printer, a bioprinter was created
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that is capable of placing cells in very specific locations. The bioprinter is shown in the figure
below.

Figure 2.1: Bioprinter.

This bioprinter works by moving the cartridge head along the x-axis, while the platform
moves along the y-axis. The platform sits upon a laboratory support jack, similar to a scissor lift,
that can be used to move the platform along the z-axis. Due to the fact that the melanocytes are
printing in a 2D pattern, the height of the platform did not need to be adjusted. The melanocyte
bio-ink is loaded into either a modified HP 26 Black Ink cartridge or a modified HP 33 Black Ink
cartridge. The cartridge can then be loaded into the bioprinter. The exact procedure for creating
the modified cartridge and the printing procedure will be explained in detail in a later section.
2.1.4 UV Lamp
The UV lamp used to expose the melanocytes to UV radiation for this research was the
UVP® 95-0042-07 Model XX-15L UV Bench Lamp. UV lamps are available in either shortwave
or longwave UV options. Shortwave UVB of around 254 nm are used to sterilize and sanitize
whereas longwave UVA of around 365 nm are used for inspection and other testing applications
[106]. This lamp is a longwave lamp that runs at 15 watts. The UV exposure and tanning procedure
will be discussed in a later section.
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2.1.5 Live/Dead Assay
The live/dead assay kit (Product ID M0795) used to determine the percentage of live and
dead cells was purchased from Marker Gene Technologies, Inc [107]. This assay kit enables the
fast and easy measurement of living and dead mammalian cells. There are two fluorescent dye
compounds included in the kit: carboxyfluorescein di-acetate (CFDA) and propidium iodide.
These dyes interact with the cells in different ways. CFDA binds to cells that have intracellular
esterase activity, a characteristic of living cells, and shows green fluorescence. Likewise,
propidium iodide only enters cells that have damaged membranes and binds with nucleic acids and
fluoresces red. This dye cannot enter live cells with intact plasma membranes. It can be assumed
that damaged plasma membranes are characteristic to dead cells. The CFDA dye has an excitation
wavelength of 475 nm and an emission wavelength of 517 nm. The propidium iodide dye has an
excitation wavelength of 493 nm and an emission wavelength of 630 nm. This assay can then be
analyzed using fluorescence microscopy. It is important to note that once the dyes are added to the
cell samples, they will no longer be useable in future experiments. The procedure used to complete
the live/dead assay test will be described in the next section.
2.2 Methods and Procedures
In this section, methods and procedures will be discussed in detail. The methods include
preparing the growth media, preparing the collagen gel, modifying and preparing the ink
cartridges, preparing the melanocyte bio-ink, the bioprinting process, the UV exposure process
and determining cell viability.
2.2.1 Preparing the Collagen Gel
The melanocytes were cultured in flasks whose bottom surface is usually treated to
optimize cell adhesion. For this project the melanocytes were printed onto a 12-well plate that had
previously been treated to optimize cell attachment. Due to the fact that the melanocytes are ejected
from the printing nozzle at such a high velocity, a layer of collagen hydrogel was added to six of
the well plates as an extra means of protection. Lining each well with a layer of collagen gel also
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helped promote cell attachment and function. According to Corning, “when used as a gel, collagen
[…] enhances expression of cell-specific morphology and function” [104]. The protocol used for
the preparation of the collagen hydrogel is as follows.
Collagen can either be used as a thick gel or as a thin coating. Thin coatings generally
promote cell adhesion whereas a thicker gel enhances the function of the cell. To accomplish the
final goal of establishing that printed melanocytes are capable of producing melanin, a gel of
significant thickness was used in the 12-well plate. The collagen used for this project was collagen
type I meaning that it is extracted from rat tail tendons. This collagen gels irreversibly at room
temperature and appropriate pH, therefore it was necessary to keep all of the materials and
equipment as cold as possible during formulation.
For the experiment, six wells were filled with a thick layer of collagen gel. The first step
was to determine the quantity of collagen gel required for each well. The manufacturer’s protocol
had several suggestions for the volume of collagen gel for different sizes of Petri dishes. The data
was extrapolated to figure out the volume of collagen for each 22.1 mm diameter well in the 12well plate. The volume used for each well was approximately 0.35 mL. Therefore, a total volume
of 2.1 mL of the collagen gel was required to be formulated. To be safe, a total volume of 2.5 mL
of collagen gel was formulated. Initially, the manufacturer’s protocol was followed for the
formation of the collagen gel. However, after attempting this procedure twice, the collagen never
formed a hydrogel. At this point, an alternate protocol that was created by a fellow graduate student
was modified and successfully used and is as follows.
A small cooler filled with ice was prepared to ensure all the materials stayed as cold as
possible. Into a cold centrifuge tube, 2.5 mL of cold, sterile Corning collagen I was added along
with 0.25 mL of cold growth media. The contents of the centrifuge tube were thoroughly mixed
and placed back into the ice. As previously mentioned, there are two conditions that need to be
satisfied for the collagen to gel: room temperature and close to proper pH. After attempting this
procedure several times, it was found that the collagen gelled best when the pH was between
physiological (7.0) and slightly basic (8.0). Therefore, the next step in the gel formation process
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was to test the pH. If the pH was too acidic, small amounts of cold sodium hydroxide, or NaOH,
was added in 5 µL increments until the pH reached the desired range. Likewise, if the pH was too
basic, small amounts of cold hydrochloric acid, or HCl, was added in 5 µL increments until the
pH reached the desired range. This pH-adjusted solution was left on ice until the well plate was
ready to be prepared. As shown in the illustration below, six of the 12 wells were treated with 0.45
mL of the collagen gel and placed into a 37˚C incubator for 30 minutes to allow the gel to solidify.
After the incubation period, any ungelled collagen was removed. This left approximately 0.35 mL
of the gelled collagen hydrogel in each of the six wells.

Illustration 2.1: 12-Well Plate Collagen Gel
Diagram. A thick layer of collagen gel was placed
into the first and third columns of the well plate.
The second and fourth columns were left empty to
be used as positive and negative controls.

2.2.2 Modifying and Preparing Cartridges
The bioprinter mentioned previously was created using parts of an HP Officejet 330 printer
which has been discontinued for some time. This printer has two compatible ink cartridges: HP 26
black ink cartridge and HP 33 black ink cartridge. These cartridges are identical and only differ in
the viscosity of their ink. However, both of these cartridges have also been discontinued. The
cartridges available were either expired or remanufactured. Compatibility issues were experienced
when using remanufactured cartridges. Therefore, it was necessary to find cartridges with the most
recent expiration dates. One problem that resulted from the expired cartridges was that,
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occasionally, the expired ink would leak out of the nozzle and destroy the circuitry rendering them
useless. Out of the six ink cartridges ordered, two-thirds of them could not be salvaged due to the
fact that the expired ink had damaged the circuitry. The damage can be seen in the figure below.

Figure 2.2: Ink Cartridge Damage. Shown on
the left is one of the clean, working cartridges.
Shown on the right is one of the
nonfunctioning cartridges. As can be seen,
expired ink had leaked out of the nozzle and
damaged the circuitry. The ink destroyed the
film protecting the delicate circuitry
underneath.

Two cartridges remained that could be modified to print cells. The process of modifying
the ink cartridges into cell cartridges consists of five steps and is shown in the figure below. The
first step is to remove the green top of the cartridge. To do this, two small slits were cut into the
top of the cartridge on opposite sides using a rotary tool. The majority of the black ink was drained
from the cartridge. Again, the rotary tool was used to carefully remove the green top of the
cartridge as well as the connected sensors that measure the level of the ink. The remaining ink was
drained. The second step is to remove the metal mesh filter located at the bottom of the cartridge
just above the nozzle. This filter was removed using a pair of pliers. The third step is to clean the
cartridge thoroughly with dH2O to remove any residual ink. The cartridge was set aside to dry.
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The fourth step is to fashion the small tube that holds the bio-ink inside the cartridge. The rotary
tool was used once again to cleanly remove the bottom, angled portion of a microcentrifuge tube.
The fifth step involved inserting this tube firmly into the area where the mesh filter was removed.
At this time, the modified cartridge was ready to be used. The main issue that was observed while
using the modified cartridge was that the nozzle was prone to blockage by the cells. To ensure
this did not happen, the cartridge was cleaned using dH2O and sonicated for twenty minutes before
and after each use.

Figure 2.3: The five steps of modifying a printer cartridge to print cells instead of ink.

2.2.3 Preparing the Melanocyte Bio-Ink
Once the melanocytes were subcultured and counted, the cells were separated into three
batches containing approximately 150,000 cells each. These three batches would be used to print
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three samples, seed three samples and as three control samples. This resulted in each well
containing about 50,000 cells. It was recommended that for a 96-well plate, approximately 5,000
cells should be placed in each well. Likewise, a 12-well plate should contain approximately 40,000
cells in each well. After printing several times, it was observed that a significant number of cells
disappeared (got clogged in the nozzle) or died during the printing process. Therefore, the initial
concentration was increased from 40,000 to 50,000 cells/well to account for this loss. After
separating the melanocytes into three batches, one batch was chosen to become the bio-ink.
Dulbecco’s Phosphate Buffered Saline (ATCC 30-2200), or D-PBS, was added to one batch of the
melanocyte bio-ink to decrease viscosity enabling it to be printed using the bioprinter. At this
point, the bio-ink was ready to be printed immediately.
2.2.4 Printing Process
The process to use the bioprinter was developed by the students who created the bioprinter.
However, modifications to the process were made to suit the individual needs of this research. The
first step of the printing process was to create the template of the well plate that is to be printed.
That template is shown in the figure below. When the printer is sent the command to print, the bioink will only be deposited in the three gray circles.

Illustration 2.2: Word Document Template
for Printing Cells.

The next step was to ensure that the printer cartridge has been sonicated for twenty minutes
and left to airdry completely. Next, the cartridge was filled with 20 µL of DH2O and a test run of
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the printing was done to figure out where the printer was depositing the bio-ink. After the test run,
the 12-well plate was positioned so that the bio-ink would be deposited into the first row of three
wells. Once the remaining dH2O was removed from the cartridge, 20 µL of the bio-ink could be
loaded into the cartridge. It was important to remember to re-suspend the bio-ink each time that
the cartridge was refilled to ensure the correct number of cells were printed with each pass. Each
time the cartridge was loaded with bio-ink, four copies of the template were printed. After the print
was completed, the cartridge was removed and cleaned with dH2O using a pipette. This process
was repeated until all of the bio-ink was used. At this point, one of the remaining batches of
melanocytes was manually seeded onto the row of wells lined with the collagen hydrogel. The
other remaining batch of melanocytes was manually seeded onto the row of control wells that did
not contain the hydrogel.
2.2.5 Exposure of Melanocytes to UV Radiation
Part of proving the viability of printed melanocytes is to ensure that they still maintain the
same functions as non-printed cells. The main function of melanocytes, as previously mentioned,
is to produce pigment or melanin after exposure to UV radiation. Therefore, a very important step
in this experiment was the exposure of the melanocytes to UV radiation to induce melanin
production.
The UV lamp was rested upon four plastic containers that held the lamp parallel to the
samples, approximately 10 cm above the well plate. The top of the well plate was removed and
the melanocytes were exposed to ten minutes of UV radiation, once every other day for seven
days. The media was changed immediately after the UV exposure. The cells were analyzed for
their pigment content 24 hours after the last exposure to UV radiation using an electron
microscope.
2.2.6 Cell Viability
The manufacturer’s protocol was followed to perform the live/dead assay on the
melanocyte samples [107]. The first step of the protocol was to prepare what is referred to as the
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“working solution” which contains different proportions of the two dyes: carboxyfluorescein diacetate and propidium iodide. Into a centrifuge tube, 12 mL of PBS was added along with 6 µL of
4mM carboxyfluorescein solution and 24 µL of 2mM propidium iodide solution and thoroughly
mixed. Using this working solution, the ratio of the green fluorescence at 630 nm to red
fluorescence at 517 nm will result in the ratio of live to dead cells in the sample.
Next, the media of the melanocyte samples was removed. The cells were then washed with
D-PBS (ATCC® 302200™) with the intent to remove the serum esterase activity. Into each well
of the 12-well plate, 1.1875 mL of the working solution was added. The well plate was then
returned to the incubator for 30-45 minutes. After the cells were treated with the fluorescent dyes,
the samples were viewed using a fluorescent microscope equipped with a conventional fluorescein
longpass and dual emission filter. This filter allowed for simultaneous viewing of both types of
fluorescence. At this point, images were recorded and data collected.
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Chapter 3: Results
3.1 Cell Viability
Experiment A and experiment B were conducted simultaneously. A live/dead cell assay
was performed on the first well in both experiments. However, no fluorescence was able to be
excised for the samples from experiment B. This left four wells of each sample to be analyzed for
cell viability. Images of each of these wells are included in Appendices 1-15. The samples were
gathered on the 12th day after initial seeding and printing. Well 2 and well 3 for each sample group
was trypsinized and placed into separate vials. Each of these 12 cell samples were counted using
a hemocytometer and cell densities were calculated. The following table shows the average
percentages of live melanocytes as compared to the original seeding density of 50,833 cells/well
and the standard deviation. An extended table of all data can be viewed in its entirety in Appendix
18.
Table 3.1: Cell Viability of Melanocytes after five UV radiation exposures.

Average Percentage of Live
Cells After UV Exposure
59%
182%
162%

Control
Seeded
Printed

Standard Deviation
13%
39%
10%

Melanocyte Proliferation
Percentage of Live Cells
After Printing and UV Exposure

250%
200%
150%
100%

182%

162%

SEEDED

PRINTED

50%
59%
0%
CONTROL

Figure 3.1: Graph cart of the percentage of cell proliferation of the three sample groups.
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3.2 Melanin Expression
Proving that the melanocytes still maintained their function after the printing process was
an important part of this research. The samples were exposed to UV radiation as previously
described. Melanosomes and melanin granules were seen and imaged as shown in the figure below.

Figure 3.2: Printed melanocytes expressing melanosomes after five UV radiation doses.
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Chapter 4: Discussion
4.1 Cell Viability
As shown in Table 3.1, both the manually seeded melanocytes and the bioprinted
melanocytes averaged above 100% meaning that both sample groups had significant cell growth
after the printing process. These percentages would most likely be even higher if some of the
following issues could have been avoided. Firstly, the collagen hydrogel was very sensitive. If the
well plate was moved too violently the hydrogel would detach from the well plate and float on top
of the media. Partial detachment of the hydrogel would inevitably occur during the printing process
due to the fact that the printing stage would shake forcefully. Once the hydrogel, which was
embedded with melanocytes, was floating in the media, it was difficult to change the media.
Extreme care was taken to only remove spent media using syringes; however, it is safe to assume
that a small number of live cells were accidently removed during this process.
As expected, the melanocytes embedded themselves into the hydrogel. However, it was
observed that once the hydrogel detached from the well plate, some of the melanocytes would fall
down and attach to the bottom of the well. When analyzing cell viability, the cells were collected
from each well and counted. However, additional loss of viable cells was experienced in this phase
of the experiment. After the cells were tryspinized, both the hydrogel and melanocytes were
collected into tubes and centrifuged. When the supernatant was aspirated, some of the hydrogel
(and embedded melanocytes) would also be removed resulting in percentages slightly less than
true values.
4.2 Melanin Expression
Proving that the melanocytes still maintained their function after the printing process was
an important part of this research. As shown in Figure 3.2, melanosomes and melanin granules
were observed in the printed melanocytes indicating that they still retained some form of function.
This pigmentation was extremely light but was to be expected. As specified by the manufacturer,
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these melanocytes came from the foreskin of lightly-pigmented individuals. This suggests that the
melanin produced by the melanocytes was most likely pheomelanin.
One problem experienced during the UV exposure process was that it usually takes
upwards of 10 doses to start expressing melanin, especially in light-skinned individuals. By the 5th
dose, the melanocytes had already exceeded 100% confluency and started to die due to
overcrowding. Shown in the figure below is one of the melanocyte control samples at 6 days and
again at 10 days. The once thriving melanocyte culture began to develop a more rounded
morphology indicating unfavorable conditions and the onset of cell apoptosis.

Figure 4.1: Control samples at 6 days (left) and 10 days (right). The rounded morphology indicates dying cells.

Another issue occurred with the UV-A lamp that was available. The wavelength of the
lamp was 365 nm, which is associated with causing the most concentrated number of molecular
lesions in the cells and higher rates of cell death [75]. This is supported by the significant decrease
in cell density of the control samples. Most of the melanocytes in both of the other sample groups
had become embedded in the hydrogel or trapped underneath. The hydrogel protected these
melanocytes from some of the damaging effects of the UV radiation that caused extensive cell
death in the control samples. The control samples incurred a 41 ± 13% cell death. A lamp that
emitted UV-B radiation would have been more successful at producing pigmentation as supported
by the literature [77].
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Chapter 5: Conclusions
Melanocytes were successfully printed using a bioprinter, showed significant cell growth
and still maintained their overall function after multiple exposures to UV radiation. Analysis of
cell viability showed that melanocytes that were bioprinted onto a collagen hydrogel showed a 62
± 10% increase of cells as compared to the initial seeding density. Also, melanosomes and lightlypigmented melanin granules were able to be seen in the printed cells. These findings show promise
for the incorporation of melanocytes with keratinocytes and fibroblasts to produce bioprinted skin
capable of developing pigmentation and acting as a sufficient physical barrier for the body, moving
ever so closer to fully-functional, bioprinted skin.
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Appendix 1: Culturing Melanocyte Procedure
The first step of the culturing process involved preparation of the melanocyte growth media
following the manufacturer’s protocol [102]. The components of the melanocyte growth kit were
obtained and warmed in a water bath to 37˚C. Under aseptic conditions in a laminar flow hood, all
of the components of the growth kit were added to a bottle of dermal cell basal medium in specific
proportions. The melanocyte growth kit contained the following chemical components: 0.5 mL rh
insulin, 0.5 mL ascorbic acid, 15 mL L-glutamine, 0.5 mL epinephrine, 80 µL calcium chloride
and 5 mL of a proprietary formulation referred to as M8 supplement. Three optional components
were listed by the manufacturer in the protocol: gentamicin-amphotericin B solution, a penicillinstreptomycin-amphotericin B antibiotic solution and phenol red.
At the beginning of this research, only 0.5 mL of the penicillin-streptomycin-amphotericin
B antibiotic solution was added to the growth media. Both the gentamicin-amphotericin B solution
and the phenol red were not available when the growth media was originally formulated. As a
result, great care was exercised when handling the media to minimize the chance of contamination.
Also, the pH was tested regularly to ensure that it was close to physiological pH. Throughout the
course of this research, several issues were experienced that involved the variation of the pH of
the growth media. These problems were solved by the addition of phenol red which proved to be
greatly useful in visually ensuring the correct pH. This also became important later when preparing
the collagen gel described later in this section.
The complete growth media was gently swirled to thoroughly mix all the components and
stored in a refrigerator between 2˚C and 8˚C. The manufacturer advised not to heat and cool the
growth media more than a couple times. Therefore, the growth media was separated into 50 mL
conical tubes to be used individually. This method also helped to reduce contamination of the
growth media. The manufacturer also advised to avoid exposure of the growth media to sunlight
and UV radiation. Each container of media was wrapped in aluminum foil to reduce exposure. The
shelf-life of the complete melanocyte growth media is approximately 30 days.
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The melanocytes were cultured and subcultured following the manufacturer’s protocol
[102]. The cells were seeded at an initial seeding density of 5,000 cells/cm 2 into a 75 cm2 cell
culture flasks. The protocol called for 5 mL of growth media per 25 cm2. Therefore, this size flask
required 15 mL of pre-warmed growth media. For the initial culture, the frozen vial of melanocytes
was thawed and added to the 75 cm2 cell culture flask filled previously with 15 mL of pre-warmed
growth media. The flask was then placed in an incubator at 37˚C and 5% CO2 atmosphere for
approximately 24 to 36 hours. At that time, the media was removed with care not to disturb the
monolayer. Once again, 15 mL of pre-warmed growth media was added and the flasks were placed
back in the incubator. The media was changed every 48 hours to ensure the melanocytes had
sufficient nutrients to grow and multiply. The flask was also monitored daily under a microscope
to determine the percent of cellular confluence. The melanocytes should be subcultured at about
80% confluency, which took about 7 to 9 days to develop.
The melanocytes were passaged when the cells reached 80% to 90% confluency. First, the
media was removed without disturbing the monolayer. The monolayer was rinsed twice with 4.5
mL of D-PBS (ATCC® 302200™) to remove any remaining growth media. An equal volume of
pre-warmed trypsin-EDTA solution (ATCC® PCS-999-003™) was added to the flask and rocked
back and forth to cover all the cells with trypsin. The cells were then observed under a microscope
for about three minutes to determine when all of the melanocytes rounded up and detached from
the flask. This stage is very important because melanocytes are very sensitive to overtrypsinization. At this point, 4.5 mL of trypsin neutralizing solution (ATCC® PCS-999-004™)
was added to the flask to neutralize the trypsin. The detached cells, along with the solution, was
then added to a centrifuge tube. The original flask was again rinsed with 5 mL of D-PBS to collect
any remaining melanocytes that might still remain in the flask and this too was added to the
centrifuge tube. The tube was then centrifuged at 150 x g for 5 minutes. This step pushed all of the
melanocytes to the bottom of the tube so that the rest of the solution could be aspirated. The cells
were re-suspended in 1 mL of pre-warmed growth media. The viable cells were then counted using
trypan blue (Thermo Fisher Scientific 1525006) and a hemocytometer.
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At this point, the cells could either be seeded in a new flask, frozen to be used at a later
time or printed using the bioprinter. To freeze the melanocytes, approximately 1,000,000 cells
were placed into sterile cryogenic storage vials along with cell culture freezing
media (ATCC® 30-2600™) that contains 10% DMSO. The cryovials were then placed into a
controlled rate freezing apparatus that was filled with alcohol to ensure that the temperature
dropped at a rate of -1˚C per minute. If the temperature drops too quickly the cells will be damaged.
This container was placed into a freezer at -70˚C for 24 hours. After that time, the cryovials were
removed from the freezing apparatus and transferred into a deep temperature freezer at -140˚C
where they could be stored for years.
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Appendix 2: Control Samples at 48 hours

Experiment A: Well 2

Experiment A: Well 3

Experiment B: Well 2

Experiment B: Well 3

Control samples of melanocytes shown above. Images taken 2 days after seeding. Cells were
exposed to 10 minutes of UV radiation as described previously, media was changed and then
imaged. Sparsity of cells expected.
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Appendix 3: Control Samples at 96 hours

Experiment A: Well 2

Experiment A: Well 3

Experiment B: Well 2

Experiment B: Well 3

Control samples of melanocytes shown above. Images taken 4 days after seeding. Cells were
exposed to 10 minutes of UV radiation as described previously, media was changed and then
imaged. Increased number of melanocytes can be seen in all wells.
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Appendix 4: Control Samples at 144 hours

Experiment A: Well 2

Experiment A: Well 3

Experiment B: Well 2

Experiment B: Well 3

Control samples of melanocytes shown above. Images taken 6 days after seeding. Cells were
exposed to 10 minutes of UV radiation as described previously, media was changed and then
imaged. Increased number of melanocytes can be seen in all wells. Cell morphology is healthy as
expected. Cell confluency reached.
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Appendix 5: Control Samples at 192 hours

Experiment A: Well 2

Experiment A: Well 3

Experiment B: Well 2

Experiment B: Well 3

Control samples of melanocytes shown above. Images taken 8 days after seeding. Cells were
exposed to 10 minutes of UV radiation as described previously, media was changed and then
imaged. Equivalent number of melanocytes can be seen in all wells. Cell morphology is becoming
more rounded indicating unhealthy cells and cell death. Cell confluency reached.
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Appendix 6: Control Samples at 240 hours

Experiment A: Well 2

Experiment A: Well 3

Experiment B: Well 2

Experiment B: Well 3

Control samples of melanocytes shown above. Images taken 10 days after seeding. Cells were
exposed to 10 minutes of UV radiation as described previously, media was changed and then
imaged. Decreased number of melanocytes can be seen in all wells. Cell morphology is becoming
more rounded indicating unhealthy cells and increased cell death experienced. Cell death attributed
to molecular lesions caused by UV radiation exposure.
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Appendix 7: Seeded Samples on Gel at 48 hours

Experiment A: Well 2

Experiment A: Well 3

Experiment B: Well 2

Experiment B: Well 3

Seeded samples of melanocytes shown above. Images taken 2 days after seeding. Cells were
manually seeded onto a collagen hydrogel, exposed to 10 minutes of UV radiation as described
previously, media was changed and then imaged. Cells are embedded in the hydrogel and attached
to the bottom of the well plate. Sparsity of cells expected.
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Appendix 8: Seeded Samples on Gel at 96 hours

Experiment A: Well 2

Experiment A: Well 3

Experiment B: Well 2

Experiment B: Well 3

Seeded samples of melanocytes shown above. Images taken 4 days after seeding. Cells were
manually seeded onto a collagen hydrogel, exposed to 10 minutes of UV radiation as described
previously, media was changed and then imaged. Increased number of melanocytes can be seen in
all wells. Cells are embedded in the hydrogel and attached to the bottom of the well plate. Collagen
hydrogel becomes more detached from well plate.
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Appendix 9: Seeded Samples on Gel at 144 hours

Experiment A: Well 2

Experiment A: Well 3

Experiment B: Well 2

Experiment B: Well 3

Seeded samples of melanocytes shown above. Images taken 6 days after seeding. Cells were
manually seeded onto a collagen hydrogel, exposed to 10 minutes of UV radiation as described
previously, media was changed and then imaged. Increased number of melanocytes can be seen in
all wells. Cells are embedded in the hydrogel and attached to the bottom of the well plate. Cell
morphology is healthy as expected. Collagen hydrogel becomes more detached from well plate.
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Appendix 10: Seeded Samples on Gel at 192 hours

Experiment A: Well 2

Experiment A: Well 3

Experiment B: Well 2

Experiment B: Well 3

Seeded samples of melanocytes shown above. Images taken 8 days after seeding. Cells were
manually seeded onto a collagen hydrogel, exposed to 10 minutes of UV radiation as described
previously, media was changed and then imaged. Equivalent number of melanocytes can be seen
in the bottom of all wells as confluency is reached. Increased number of melanocytes can be seen
embedded in the hydrogels. Cell morphology is healthy as expected. Collagen hydrogel becomes
more detached from well plate.
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Appendix 11: Seeded Samples on Gel at 240 hours

Experiment A: Well 2

Experiment A: Well 3

Seeded samples of melanocytes shown above. Images taken 10 days after seeding. Cells were
manually seeded onto a collagen hydrogel, exposed to 10 minutes of UV radiation as described
previously, media was changed and then imaged. Equivalent number of melanocytes can be seen
in the bottom of all wells as confluency is reached. Increased number of melanocytes can be seen
embedded in the hydrogels. Cell morphology is healthy overall especially ones embedded in the
hydrogel.
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Appendix 12: Printed Samples on Gel at 48 hours

Experiment A: Well 2

Experiment A: Well 3

Experiment B: Well 2

Experiment B: Well 3

Printed samples of melanocytes shown above. Images taken 2 days after seeding. Cells were
bioprinted onto a collagen hydrogel, exposed to 10 minutes of UV radiation as described
previously, media was changed and then imaged. Cells are embedded in the hydrogel and attached
to the bottom of the well plate. Sparsity of cells expected. Overall cell morphology is healthy
except in experiment A well 3. An excess of dead cells is seen throughout the sample directly after
printing.
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Appendix 13: Printed Samples on Gel at 96 hours

Experiment A: Well 2

Experiment A: Well 3

Experiment B: Well 2

Experiment B: Well 3

Printed samples of melanocytes shown above. Images taken 4 days after seeding. Cells were
bioprinted onto a collagen hydrogel, exposed to 10 minutes of UV radiation as described
previously, media was changed and then imaged. Increased number of melanocytes can be seen in
all wells. Cells are embedded in the hydrogel and attached to the bottom of the well plate. Collagen
hydrogel becomes more detached from well plate. Overall cell morphology is healthy except in
experiment B well 3. Dead cells are seen embedded in the collagen hydrogel.
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Appendix 14: Printed Samples on Gel at 144 hours

Experiment A: Well 2

Experiment A: Well 3

Experiment B: Well 2

Experiment B: Well 3

Printed samples of melanocytes shown above. Images taken 6 days after seeding. Cells were
bioprinted onto a collagen hydrogel, exposed to 10 minutes of UV radiation as described
previously, media was changed and then imaged. Increased number of melanocytes can be seen in
all wells. Cells are embedded in the hydrogel and attached to the bottom of the well plate. Collagen
hydrogel becomes more detached from well plate. Overall cell morphology is healthy in all wells.
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Appendix 15: Printed Samples on Gel at 192 hours

Experiment A: Well 2

Experiment A: Well 3

Experiment B: Well 2

Experiment B: Well 3

Printed samples of melanocytes shown above. Images taken 8 days after seeding. Cells were
bioprinted onto a collagen hydrogel, exposed to 10 minutes of UV radiation as described
previously, media was changed and then imaged. Equivalent number of melanocytes can be seen
in the bottom of all wells as confluency is reached. Increased number of melanocytes can be seen
embedded in the hydrogels. Collagen hydrogel becomes more detached from well plate. Overall
cell morphology is healthy in all wells.
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Appendix 16: Printed Samples on Gel at 240 hours

Experiment A: Well 2

Experiment A: Well 3

Experiment B: Well 2

Experiment B: Well 3

Printed samples of melanocytes shown above. Images taken 10 days after seeding. Cells were
bioprinted onto a collagen hydrogel, exposed to 10 minutes of UV radiation as described
previously, media was changed and then imaged. Equivalent number of melanocytes can be seen
in the bottom of all wells as confluency is reached. Increased number of melanocytes can be seen
embedded in the hydrogels. Cell morphology is healthy overall especially ones embedded in the
hydrogel. Melanin expression is also evident as shown in Figure 3.2.
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Appendix 17: Melanocyte Live/Dead Assay
Images of melanocyte
fluorescence is shown to the
left. Top: Printed melanocytes
imaged at 10 days after initial
printing. Majority of the cells
are green fluorescent indicating
live cells. Morphology of cells
is varying with some healthy
cells and some unhealthy cells.
Several red fluorescent cells
can also be seen indicating
dead cells. Bottom: Seeded
melanocytes imaged at 10 days
after initial printing. Majority
of the cells are green
fluorescent indicating live
cells. Morphology of cells is
varying with mostly healthy
cells and some unhealthy cells.
Several red fluorescent cells
can also be seen indicating
dead cells. As can be seen,
there is more seeded
melanocytes than printed
melanocytes. This finding
corresponds to the average
percentages of live cells
reported in Appendix 18.

Printed Melanocytes at 10 days

Seeded Melanocytes at 10 days
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Appendix 18: Data and Percentage of Viable Melanocyte Calculations

Control
Well 2A
Well 3A
Well 2B
Well 3B
Seeded
Well 2A
Well 3A
Well 2B
Well 3B
Printed
Well 2A
Well 3A
Well 2B
Well 3B

Total
Cells

Average

Cell
Density

Percentage of Live
Cells After Printing
and UV Exposure

Average Percentage of
Live Cells After Printing
and UV Exposure

Standard
Deviation

5
7
3
9

1.25
1.75
0.75
2.25

25000
35000
15000
45000

49%
69%
30%
89%

59%

13%

27
10
23
14

6.75
2.5
5.75
3.5

135000
50000
115000
70000

266%
98%
226%
138%

182%

39%

14
19
17
16

3.5
4.75
4.25
4

70000
95000
85000
80000

138%
187%
167%
157%

162%

10%

Hemocytometer/Cell Density Formula:
𝑇𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙𝑠⁄𝑚𝑙 =

𝑇𝑜𝑡𝑎𝑙 𝐶𝑒𝑙𝑙𝑠 𝐶𝑜𝑢𝑛𝑡𝑒𝑑 ∗ 𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝐹𝑎𝑐𝑡𝑜𝑟 ∗ 10,000 𝑐𝑒𝑙𝑙𝑠⁄𝑚𝑙
# 𝑜𝑓 𝑆𝑞𝑢𝑎𝑟𝑒𝑠

Percentage of Live Cells After Printing and UV Exposure Formula:
% 𝑜𝑓 𝐿𝑖𝑣𝑒 𝐶𝑒𝑙𝑙𝑠 =

𝐶𝑒𝑙𝑙 𝐷𝑒𝑛𝑠𝑖𝑡𝑦
𝑂𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝐶𝑒𝑙𝑙 𝐷𝑒𝑛𝑠𝑖𝑡𝑦

Sample Calculation for Control Experiment A Well 2 Sample
Hemocytometer/Cell Density:
𝑇𝑜𝑡𝑎𝑙 𝐶𝑒𝑙𝑙𝑠 𝐶𝑜𝑢𝑛𝑡𝑒𝑑 ∗ 𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝐹𝑎𝑐𝑡𝑜𝑟 ∗ 10,000 𝑐𝑒𝑙𝑙𝑠⁄𝑚𝑙
# 𝑜𝑓 𝑆𝑞𝑢𝑎𝑟𝑒𝑠
⁄
5 ∗ 2 ∗ 10,000 𝑐𝑒𝑙𝑙𝑠 𝑚𝑙
=
= 25,000 𝑐𝑒𝑙𝑙𝑠/𝑚𝑙
4

𝑇𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙𝑠⁄𝑚𝑙 =

Percentage of Live Cells After Printing and UV Exposure:
% 𝑜𝑓 𝐿𝑖𝑣𝑒 𝐶𝑒𝑙𝑙𝑠 =

𝐶𝑒𝑙𝑙 𝐷𝑒𝑛𝑠𝑖𝑡𝑦
25,000 𝑐𝑒𝑙𝑙𝑠/𝑚𝑙
=
= 49%
𝑂𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝐶𝑒𝑙𝑙 𝐷𝑒𝑛𝑠𝑖𝑡𝑦 50,833 𝑐𝑒𝑙𝑙𝑠/𝑚𝑙
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Appendix 19: Error Analysis Calculations
Mean Value Formula:
𝑛

1
𝑋̅ = ∑ 𝑋𝑖
𝑛
𝑖=1

Standard Deviation Formula:

𝑛

1
𝛿𝑋 = √
∑(𝑋𝑖 − 𝑋̅)2
𝑛(𝑛 − 1)
𝑖=1

Sample Calculation for Control Sample
Mean Value:
𝑛

1
49 + 69 + 30 + 89
𝑋̅ = ∑ 𝑋𝑖 =
= 59%
𝑛
4
𝑖=1

Standard Deviation:

𝑛

1
𝛿𝑋 = √
∑(𝑋𝑖 − 𝑋̅)2
𝑛(𝑛 − 1)
𝑖=1

=√

1
[(49 − 59)2 + (69 − 59)2 + (30 − 59)2 + (89 − 59)2 ] = 13%
4(4 − 1)

𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑜𝑓 𝐿𝑖𝑣𝑒 𝑀𝑒𝑙𝑎𝑛𝑜𝑐𝑦𝑡𝑒𝑠 𝑖𝑛 𝐶𝑜𝑛𝑡𝑟𝑜𝑙 𝑆𝑎𝑚𝑝𝑙𝑒𝑠 = 59 ± 13%
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